These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 19241077

  • 41. Increased alpha1-adrenergic activity in the rat bladder by depletion of ovarian hormones.
    Dmitrieva N.
    J Urol; 2007 Dec; 178(6):2677-82. PubMed ID: 17945282
    [Abstract] [Full Text] [Related]

  • 42. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens.
    Rowley PT, Farley BA, LaBella S, Giuliano R, Leary JF.
    Int J Cell Cloning; 1992 Jul; 10(4):232-40. PubMed ID: 1645031
    [Abstract] [Full Text] [Related]

  • 43. Involvement of ERK/MAPK pathway in megakaryocytic differentiation of K562 cells induced by 3-hydrogenkwadaphnin.
    Meshkini A, Yazdanparast R.
    Toxicol In Vitro; 2008 Sep; 22(6):1503-10. PubMed ID: 18586450
    [Abstract] [Full Text] [Related]

  • 44. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Bakić M, Ozawa K, Uemura N, Nishikawa M, Tojo A, Takahashi K, Tani K, Zaike Y, Ikebuchi K, Asano S.
    Leuk Res; 1993 Dec; 17(12):1079-82. PubMed ID: 7504152
    [Abstract] [Full Text] [Related]

  • 45. [Effect of berberine on the differentiation and apoptosis of K562 cell line].
    Jin L, Liao HJ, Zhang MY, Liu QY, Wang YF.
    Zhong Yao Cai; 2009 Mar; 32(3):384-8. PubMed ID: 19565717
    [Abstract] [Full Text] [Related]

  • 46. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
    Liu T, Yao Y, Zhang G, Wang Y, Deng B, Song J, Li X, Han F, Xiao X, Yang J, Xia L, Li YJ, Plachynta M, Zhang M, Yan C, Mu S, Luo H, Zacksenhaus E, Hao X, Ben-David Y.
    Oncotarget; 2017 Mar 07; 8(10):16728-16743. PubMed ID: 28052010
    [Abstract] [Full Text] [Related]

  • 47. Hyperthermia induces differentiation without apoptosis in permissive temperatures in human erythroleukaemia cells.
    Sharif-Khatibi L, Kariminia A, Khoei S, Goliaei B.
    Int J Hyperthermia; 2007 Dec 07; 23(8):645-55. PubMed ID: 18097851
    [Abstract] [Full Text] [Related]

  • 48. Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562.
    Hirase N, Yanase T, Mu Y, Muta K, Umemura T, Takayanagi R, Nawata H.
    Leuk Res; 2000 May 07; 24(5):393-400. PubMed ID: 10785261
    [Abstract] [Full Text] [Related]

  • 49. A natural small molecule induces megakaryocytic differentiation and suppresses leukemogenesis through activation of PKCδ/ERK1/2 signaling pathway in erythroleukemia cells.
    Yang J, Qiu J, Hu Y, Zhang Y, Chen L, Long Q, Chen J, Song J, Rao Q, Li Y, Gu W, Hao X.
    Biomed Pharmacother; 2019 Oct 07; 118():109265. PubMed ID: 31545282
    [Abstract] [Full Text] [Related]

  • 50. Effects of hyperthermia on the differentiation and growth of K562 erythroleukemic cell line.
    Goliaei B, Rafiei M, Soheili Z.
    Leuk Res; 2004 Dec 07; 28(12):1323-8. PubMed ID: 15475074
    [Abstract] [Full Text] [Related]

  • 51. The apoptosis of HEL cells induced by hydroxyurea.
    Gui CY, Jiang C, Xie HY, Qian RL.
    Cell Res; 1997 Jun 07; 7(1):91-7. PubMed ID: 9261566
    [Abstract] [Full Text] [Related]

  • 52. Cyclic nucleotide response element binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation.
    Di Pietro R, di Giacomo V, Caravatta L, Sancilio S, Rana RA, Cataldi A.
    J Cell Biochem; 2007 Mar 01; 100(4):1070-9. PubMed ID: 17063485
    [Abstract] [Full Text] [Related]

  • 53. A critical role for the co-repressor N-CoR in erythroid differentiation and heme synthesis.
    Zhang D, Cho E, Wong J.
    Cell Res; 2007 Sep 01; 17(9):804-14. PubMed ID: 17768398
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Characterization and induction of a cell line established from a patient with erythroleukemia (FAB M6).
    Kambayashi H, Kawaguchi M, Abe R, Kimura H, Kariyone S.
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb 01; 53(1):35-44. PubMed ID: 2330804
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent.
    Lau AH, Lai HK, Yeung BH, Leung SL, Tsang SY, Wong YH, Wise H.
    Prostaglandins Leukot Essent Fatty Acids; 2012 Mar 01; 86(3):119-26. PubMed ID: 22336225
    [Abstract] [Full Text] [Related]

  • 59. Diosgenin dose-dependent apoptosis and differentiation induction in human erythroleukemia cell line and sedimentation field-flow fractionation monitoring.
    Léger DY, Liagre B, Cardot PJ, Beneytout JL, Battu S.
    Anal Biochem; 2004 Dec 15; 335(2):267-78. PubMed ID: 15556566
    [Abstract] [Full Text] [Related]

  • 60. Prazosin increases immobility episodes in taiep rats without changes in the properties of alpha1 receptors.
    Cortés MD, Arias-Montaño JA, Eguibar JR.
    Neurosci Lett; 2007 Jan 29; 412(2):159-62. PubMed ID: 17194536
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.